| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035818009 |
| P356 | DOI | 10.2165/00003495-197101030-00003 |
| P698 | PubMed publication ID | 4256645 |
| P2093 | author name string | Ogston D | |
| Douglas AS | |||
| P2860 | cites work | The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor | Q28630878 |
| In vivo effects of Agkistrodon rhodostoma venom: studies with fibrinogen-131I | Q34082770 | ||
| AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER. | Q34257237 | ||
| WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. | Q34257361 | ||
| Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase | Q34276086 | ||
| Genetic control of dicumarol levels in man | Q34281294 | ||
| Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors | Q35573276 | ||
| Factors influencing platelet function: adhesion, release, and aggregation. | Q39878702 | ||
| Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system | Q40319431 | ||
| Recent progress in thrombolytic therapy | Q41224467 | ||
| Streptokinase Therapy in Acute Major Pulmonary Embolism: Effectiveness and Problems | Q49487554 | ||
| A new method for the determination of fibrinogen in small samples of plasma. | Q51059236 | ||
| Inhibition of plasmin activity by alpha-2-macroglobulin. | Q53722908 | ||
| Effect of a pyrimido-pyrimidine compound on platelet behaviour in vitro and in vivo. | Q53811754 | ||
| In vitro studies on a proteolytic enzyme from Aspergillus Oryzae (protease I). | Q54167978 | ||
| Pharmacology and toxicology of a defibrinating substance from Malayan pit viper venom. | Q54597410 | ||
| HEREDITARY TRANSMISSION OF EXCEPTIONAL RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS. THE FIRST REPORTED KINDRED. | Q54714431 | ||
| Fibrinolysis Autographs | Q59058917 | ||
| Effect of a Pyrimidopyrimidine Derivative on Thrombus Formation in the Rabbit | Q59096174 | ||
| In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor | Q68404271 | ||
| Blood fibrinolytic activity during arvin therapy | Q68439047 | ||
| Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease | Q70078955 | ||
| Reduction of platelet stickiness by phenformin plus ethyloestrenol | Q70078957 | ||
| Therapeutic defibrination in the treatment of thrombotic disease | Q70082989 | ||
| Acquired resistance to treatment with arvin | Q70099568 | ||
| Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots | Q70109074 | ||
| The second reported kindred with hereditary resistance to oral anticoagulant drugs | Q70136347 | ||
| Effect of RA233 on Platelet Function In Vitro | Q71435963 | ||
| Further studies on an inhibitor of plasminogen activation in human serum. Release of the inhibitor during coagulation and thrombus formation | Q71471218 | ||
| Heparin in the treatment of venous thrombo-embolic disease: administration, control and results | Q72090677 | ||
| Urokinase in Pulmonary Embolism | Q72309501 | ||
| Vitamin K and coumarin anticoagulants: dependence of anticoagulant effect on inhibition of vitamin K transport | Q72362207 | ||
| Thrombolytic Therapy with Streptokinase Using a Standard Dosage Scheme | Q72757743 | ||
| The plasminogen content of thrombi | Q72801541 | ||
| On the demonstration of plasmin deficiency in retracted clots of full blood and on its significance in the lysis with streptokinase | Q72958769 | ||
| The action of plasmin on fibrin and fibrinogen in blood | Q73193148 | ||
| PRACTICAL METHOD FOR THROMBOLYTIC THERAPY WITH STREPTOKINASE. MAINTENANCE OF NEARLY COMPLETE PLASMINOGEN DEPLETION ASSOCIATED WITH HIGH CIRCULATING ACTIVATOR ACTIVITY | Q76660643 | ||
| ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR | Q77143651 | ||
| CRYSTALLINE HUMAN UROKINASE: SOME PROPERTIES | Q77148775 | ||
| AMINO METHYL CYCLOHEXANE CARBOXYLIC ACID (AMCHA), A NEW SYNTHETIC FIBRINOLYTIC INHIBITOR | Q78238484 | ||
| THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION | Q78314125 | ||
| Fibrinolysis and fibrinolytic activity in man | Q78616755 | ||
| Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme | Q78770726 | ||
| Effect of the sulphonylureas on fibrinolysis | Q78834293 | ||
| Thrombotest. A new method for controlling anticoagulant therapy | Q78852647 | ||
| Proactivator function of human plasmin as shown by lysine esterase assay | Q78957333 | ||
| A comparison of the fibrinolytic and fibrinogenolytic effects of plasminogen activators and proteolytic enzymes in plasma | Q79016928 | ||
| Studies made with radioactive heparin in humans | Q79223414 | ||
| Distribution and fate of I-131-labeled components of the fibrinolysin system | Q79339056 | ||
| In-vitro and in-vivo studies of a preparation of urokinase | Q79444390 | ||
| Prolonged coagulation defect (defibrination syndrome) in Malayan viper bite | Q79603621 | ||
| The Effect of Arvin on Blood Coagulation Factors | Q93840521 | ||
| P433 | issue | 3 | |
| P921 | main subject | anticoagulant | Q215118 |
| thrombolysis | Q1931577 | ||
| anticoagulation | Q63279445 | ||
| P304 | page(s) | 228-246 | |
| P577 | publication date | 1971-01-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects | |
| P478 | volume | 1 |
| Q39929988 | Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses. | cites work | P2860 |
Search more.